Related Experiment Videos
Selenium as an anticancerogenic agent.
1Department of Pharmacology Medical University of Łódź, 90-151 Łódź, 1 Muszyńskiego Str., Poland. awojtczak@pharm.am.lodz.pl
Acta Poloniae Pharmaceutica
|October 15, 2003
Summary
Selenium acts as a crucial antioxidant, protecting cells and the body from oxidative damage and diseases like cancer. Higher selenium levels may offer protection against cancers and reduce chemotherapy side effects.
Area of Science:
- Biochemistry
- Oncology
- Nutritional Science
Background:
- Selenium is a vital trace element integral to the intracellular antioxidant system.
- This system is crucial for defending cells and the entire organism against oxidative stress and related diseases, particularly cancer.
Framework:
- The study explores selenium's role as a potential anticancerogenic agent.
- It investigates the correlation between higher plasma selenium concentrations and protection against human malignancies.
Implementation:
- The research examines the effects of administering higher selenium doses concurrently with chemotherapy.
- Focus is placed on selenium's ability to mitigate the toxicity of antineoplastic drugs.
Implications:
- Elevated selenium levels in plasma may serve as a protective factor against various human cancers.
- Selenium supplementation during chemotherapy could reduce drug toxicity without compromising therapeutic efficacy, improving patient outcomes.